We have helped 100+ companies launch


We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies.

85+

angel investors

$
50m+

funded

115

portfolio companies

Present your Company

The DESERT ANGELS ™ welcomes applications from startup or early stage companies. We evaluate applications on an ongoing basis and meet monthly from September through June.

Present your company
Created with Sketch.

Become a member

As a vibrant, growing organization, the DESERT ANGELS ™ welcomes new members. If you are an accredited investor with a tenacious appetite for helping early-stage companies succeed, we’d love to get to know you better at an upcoming dinner meeting.

Join now
Created with Sketch.
January 22, 2018

It is safe to say that there would have been no Calimmune without the early support of the Desert Angels.

Many members of the DA share our passion and see the potential for gene therapy to transform healthcare and liberate patients from chronic and incurable diseases. Their investments have helped us grow this company to what it is today. We truly hope Calimmune’s work will be life-changing for the people we plan to serve and the investors that supported us.

LOUIS BRETON - CEO | CALIMMUNE
Calimmune has assembled a world-class team of researchers, clinicians and translational experts in related fields of science and medicine to develop innovative cell-based therapies for HIV.

Latest News and Updates

A small rocket from a little-known company lifted off Sunday from the east coast of New Zealand, carrying a clutch of tiny satellites. That modest event — the first commercial launch by a U.S.-New Zealand company known as Rocket Lab — could mark the beginning of a new era in the space business, where countless […]

Keep reading

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the appointment of Maureen T. Cronin, Ph.D., as the Company’s Chief Scientific Officer and Senior Vice President as of November 16, 2018. Dr. Cronin is a veteran biotechnology, translational science and diagnostic executive. “HTG is incredibly […]

Keep reading

The artificial intelligence powered cybersecurity startup CYR3CON has completed a $1.5M seed round financing led by New York-based Scout Ventures. Many cyber attacks such as NotPetya spread through larger enterprises in seconds – leaving security teams scrambling. To address this need, CYR3CON combines artificial intelligence and information from malicious hacking communities to predict cyberattacks. For […]

Keep reading